mdl 19660 has been researched along with Thrombocytopenia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gibson, JP; Kociba, GJ; Yarrington, JT | 1 |
| Broersma, R; Gibson, JP; Loudy, DE; Sprinkle-Cavallo, J; Yarrington, JT | 1 |
2 other study(ies) available for mdl 19660 and Thrombocytopenia
| Article | Year |
|---|---|
Thrombocytopenia in rats and dogs administered the antidepressant compound MDL-19,660.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Blood Platelets; Bone Marrow; Bone Marrow Cells; Cell Count; Depression; Dogs; Dose-Response Relationship, Drug; Female; Leukocyte Count; Male; Megakaryocytes; Platelet Count; Rats; Rats, Inbred Strains; Thrombocytopenia; Triazoles | 1991 |
Short-term studies of MDL 19,660-induced canine thrombocytopenia.
Topics: Animals; Antidepressive Agents; Blood Platelets; Dogs; Female; Platelet Aggregation; Platelet Aggregation Inhibitors; Prednisone; Thrombocytopenia; Triazoles; Vacuoles | 1990 |